MBRX - Moleculin Biotech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development9,7284,5451,496625.003
Selling General and Administrative5,2294,0902,3811,146.744
Non Recurring----
Others----
Total Operating Expenses15,0258,6533,8831,771.747
Operating Income or Loss-15,025-8,653-3,883-1,771.747
Income from Continuing Operations
Total Other Income/Expenses Net3,149-1,152-43-24.317
Earnings Before Interest and Taxes-15,025-8,653-3,883-1,771.747
Interest Expense---43-24.317
Income Before Tax-11,876-9,805-3,926-1,796.064
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-11,876-9,805-3,926-1,796.064
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-11,876-9,805-3,926-1,796.064
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-11,876-9,805-3,926-1,796.064